Daniel A Breadner (Daniel Breadner)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 18

Top Topics

Squamous Cell Carcinoma

Liver Metastases

Diffusion Weighted

Small Cell Lung Cancer

Top Venues

Annals of hepato-biliary-pancreatic surgery

Current oncology (Toronto, Ont.)

Journal of medical imaging (Bellingham, Wash.)

This page only lists publications with an associated author ORCID identifier.

Publications

Saurav Verma, Daniel A Breadner, Abhenil Mittal, David A Palma, Rahul Nayak, Jacques Raphael, Mark Vincent
An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers 16 (7) (2024)
Saurav Verma, Natalie Grindrod, Daniel A Breadner, Michael Lock
The Current Role of Radiation in the Management of Cholangiocarcinoma-A Narrative Review. Cancers 16 (9) (2024)
Evelyn Waugh, Juan Glinka, Daniel A Breadner, Rachel Q Liu Hennessey, Ephraim S Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro
Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Saurav Verma, Natalie Grindrod, Daniel A Breadner, Michael Lock
The Current Role of Radiation in the Management of Cholangiocarcinoma-A Narrative Review. Cancers 16 (9) (2024)
Evelyn Waugh, Juan Glinka, Daniel A Breadner, Rachel Q Liu Hennessey, Ephraim S Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro
Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of hepato-biliary-pancreatic surgery (2024)
Saurav Verma, Daniel A Breadner, Abhenil Mittal, David A Palma, Rahul Nayak, Jacques Raphael, Mark Vincent
An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers 16 (7) (2024)
Saurav Verma, Daniel A Breadner, Abhenil Mittal, David A Palma, Rahul Nayak, Jacques Raphael, Mark Vincent
An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy. Cancers 16 (7) (2024)
Evelyn Waugh, Juan Glinka, Daniel A Breadner, Rachel Q Liu Hennessey, Ephraim S Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro
Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Evelyn Waugh, Juan Glinka, Daniel A Breadner, Rachel Q Liu Hennessey, Ephraim S Tang, Laura Allen, Stephen Welch, Ken Leslie, Anton Skaro
Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Annals of hepato-biliary-pancreatic surgery 28 (2) (2024)
Saurav Verma, Daniel A Breadner, Jacques Raphael
'Targeting' Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer-An Updated Review. Current oncology (Toronto, Ont.) 30 (4) (2023)
Preti Beatrice Tabitha Bassier, Michael S Sanatani, Daniel A Breadner, Suganija Lakkunarajah, Carolyn Scott, Caroline Esmonde-White, Eric McArthur, George Rodrigues, Mitali Chaudhary, Adam Mutsaers, Robin Sachdeva, Mark D Vincent
Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (8) (2023)
Saurav Verma, Daniel A Breadner, Jacques Raphael
'Targeting' Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer-An Updated Review. Current oncology (Toronto, Ont.) 30 (4) (2023)
Saurav Verma, Sympascho Young, Alexander V Louie, David Palma, Daniel A Breadner
The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer. Therapeutic advances in medical oncology 15 (2023)
Salma Dammak, Matthew J Cecchini, Daniel A Breadner, Aaron D Ward
Using deep learning to predict tumor mutational burden from scans of H&E-stained multicenter slides of lung squamous cell carcinoma. Journal of medical imaging (Bellingham, Wash.) 10 (1) (2023)
Salma Dammak, Matthew J Cecchini, Daniel A Breadner, Aaron D Ward
Using deep learning to predict tumor mutational burden from scans of H&E-stained multicenter slides of lung squamous cell carcinoma. Journal of medical imaging (Bellingham, Wash.) 10 (1) (2023)
Saurav Verma, Daniel A Breadner, Jacques Raphael
'Targeting' Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer-An Updated Review. Current oncology (Toronto, Ont.) 30 (4) (2023)
Anu Chinnadurai, Daniel A Breadner, Ziad Baloush, Ana Elisa Lohmann, Morgan Black, David D'Souza, Stephen Welch
Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution. Journal of gynecologic oncology (2023)
Sondos Zayed, Alexander V Louie, Daniel A Breadner, David A Palma, Rohann J M Correa
Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions. Therapeutic advances in medical oncology 15 (2023)